| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |